HEADER ISOMERASE/ISOMERASE INHIBITOR 26-MAR-12 4EC0 TITLE CRYSTAL STRUCTURE OF HH-PGDS WITH WATER DISPLACING INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: H-PGDS, GST CLASS-SIGMA, GLUTATHIONE S-TRANSFERASE, COMPND 5 GLUTATHIONE-DEPENDENT PGD SYNTHASE, GLUTATHIONE-REQUIRING COMPND 6 PROSTAGLANDIN D SYNTHASE, PROSTAGLANDIN-H2 D-ISOMERASE; COMPND 7 EC: 5.3.99.2, 2.5.1.18; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTS, HPGDS, PGDS, PTGDS2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, SOLVENT REPLACEMENT, ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DAY,A.THORARENSEN,J.I.TRUJILLO REVDAT 3 15-NOV-17 4EC0 1 REMARK REVDAT 2 02-JAN-13 4EC0 1 JRNL REVDAT 1 16-MAY-12 4EC0 0 JRNL AUTH J.I.TRUJILLO,J.R.KIEFER,W.HUANG,J.E.DAY,J.MOON,G.M.JEROME, JRNL AUTH 2 C.P.BONO,C.M.KORNMEIER,M.L.WILLIAMS,C.KUHN,G.R.RENNIE, JRNL AUTH 3 T.A.WYNN,C.P.CARRON,A.THORARENSEN JRNL TITL INVESTIGATION OF THE BINDING POCKET OF HUMAN HEMATOPOIETIC JRNL TITL 2 PROSTAGLANDIN (PG) D2 SYNTHASE (HH-PGDS): A TALE OF TWO JRNL TITL 3 WATERS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 3795 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22546671 JRNL DOI 10.1016/J.BMCL.2012.04.004 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3302 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 761 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071427. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32926 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08200 REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.85300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 36 -18.35 -49.56 REMARK 500 SER A 44 5.61 -63.10 REMARK 500 GLN A 63 106.09 76.63 REMARK 500 GLN B1063 104.88 72.57 REMARK 500 GLU B1106 127.35 -12.77 REMARK 500 GLU B1113 0.71 -68.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B1437 O REMARK 620 2 HOH A 459 O 179.4 REMARK 620 3 HOH A 412 O 89.2 90.7 REMARK 620 4 HOH B1372 O 92.3 87.1 91.9 REMARK 620 5 HOH A 423 O 92.4 88.2 83.5 173.4 REMARK 620 6 HOH B1384 O 85.3 94.9 167.9 99.1 85.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PQ A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4EE0 RELATED DB: PDB REMARK 900 RELATED ID: 4EDY RELATED DB: PDB REMARK 900 RELATED ID: 4EDZ RELATED DB: PDB DBREF 4EC0 A 1 199 UNP O60760 HPGDS_HUMAN 1 199 DBREF 4EC0 B 1001 1199 UNP O60760 HPGDS_HUMAN 1 199 SEQADV 4EC0 HIS A 0 UNP O60760 EXPRESSION TAG SEQADV 4EC0 HIS B 1000 UNP O60760 EXPRESSION TAG SEQRES 1 A 200 HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG SEQRES 2 A 200 GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU SEQRES 3 A 200 ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP SEQRES 4 A 200 TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE SEQRES 5 A 200 PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER SEQRES 6 A 200 LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU SEQRES 7 A 200 ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA SEQRES 8 A 200 ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO SEQRES 9 A 200 TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE SEQRES 10 A 200 ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN SEQRES 11 A 200 ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE SEQRES 12 A 200 GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE SEQRES 13 A 200 CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU SEQRES 14 A 200 ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL SEQRES 15 A 200 GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG SEQRES 16 A 200 PRO GLN THR LYS LEU SEQRES 1 B 200 HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG SEQRES 2 B 200 GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU SEQRES 3 B 200 ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP SEQRES 4 B 200 TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE SEQRES 5 B 200 PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER SEQRES 6 B 200 LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU SEQRES 7 B 200 ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA SEQRES 8 B 200 ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO SEQRES 9 B 200 TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE SEQRES 10 B 200 ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN SEQRES 11 B 200 ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE SEQRES 12 B 200 GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE SEQRES 13 B 200 CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU SEQRES 14 B 200 ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL SEQRES 15 B 200 GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG SEQRES 16 B 200 PRO GLN THR LYS LEU HET GSH A 201 20 HET MG A 202 1 HET 7PQ A 203 29 HET GSH B1201 20 HETNAM GSH GLUTATHIONE HETNAM MG MAGNESIUM ION HETNAM 7PQ 4-[2-(AMINOMETHYL)NAPHTHALEN-1-YL]-N-[2-(MORPHOLIN-4- HETNAM 2 7PQ YL)ETHYL]BENZAMIDE FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 4 MG MG 2+ FORMUL 5 7PQ C24 H27 N3 O2 FORMUL 7 HOH *761(H2 O) HELIX 1 1 ALA A 15 ASP A 26 1 12 HELIX 2 2 ASP A 38 LYS A 43 1 6 HELIX 3 3 SER A 44 LEU A 46 5 3 HELIX 4 4 GLN A 63 LYS A 73 1 11 HELIX 5 5 THR A 81 CYS A 101 1 21 HELIX 6 6 LYS A 108 TYR A 122 1 15 HELIX 7 7 TYR A 122 GLY A 136 1 15 HELIX 8 8 THR A 147 LYS A 164 1 18 HELIX 9 9 HIS A 171 ALA A 183 1 13 HELIX 10 10 ILE A 184 ARG A 194 1 11 HELIX 11 11 ALA B 1015 LEU B 1025 1 11 HELIX 12 12 GLU B 1035 ALA B 1037 5 3 HELIX 13 13 ASP B 1038 THR B 1045 1 8 HELIX 14 14 GLN B 1063 LYS B 1073 1 11 HELIX 15 15 THR B 1081 SER B 1100 1 20 HELIX 16 16 LYS B 1108 ASN B 1123 1 16 HELIX 17 17 ASN B 1123 GLY B 1136 1 14 HELIX 18 18 THR B 1147 LYS B 1164 1 18 HELIX 19 19 HIS B 1171 ILE B 1184 1 14 HELIX 20 20 ILE B 1184 ARG B 1194 1 11 SHEET 1 A 4 GLU A 30 ARG A 33 0 SHEET 2 A 4 TYR A 4 TYR A 8 1 N TYR A 4 O GLU A 30 SHEET 3 A 4 ILE A 53 VAL A 56 -1 O GLU A 55 N LYS A 5 SHEET 4 A 4 LEU A 59 HIS A 62 -1 O LEU A 59 N VAL A 56 SHEET 1 B 4 GLU B1030 ILE B1034 0 SHEET 2 B 4 TYR B1004 PHE B1009 1 N LEU B1006 O GLU B1030 SHEET 3 B 4 ILE B1053 VAL B1056 -1 O GLU B1055 N LYS B1005 SHEET 4 B 4 LEU B1059 HIS B1062 -1 O LEU B1059 N VAL B1056 LINK MG MG A 202 O HOH B1437 1555 1555 2.26 LINK MG MG A 202 O HOH A 459 1555 1555 2.28 LINK MG MG A 202 O HOH A 412 1555 1555 2.30 LINK MG MG A 202 O HOH B1372 1555 1555 2.34 LINK MG MG A 202 O HOH A 423 1555 1555 2.36 LINK MG MG A 202 O HOH B1384 1555 1555 2.39 CISPEP 1 ILE A 51 PRO A 52 0 0.80 CISPEP 2 ILE B 1051 PRO B 1052 0 0.76 SITE 1 AC1 17 TYR A 8 ARG A 14 TRP A 39 LYS A 43 SITE 2 AC1 17 LYS A 50 ILE A 51 PRO A 52 GLN A 63 SITE 3 AC1 17 SER A 64 7PQ A 203 HOH A 301 HOH A 402 SITE 4 AC1 17 HOH A 464 HOH A 472 HOH A 652 HOH A 684 SITE 5 AC1 17 ASP B1097 SITE 1 AC2 6 HOH A 412 HOH A 423 HOH A 459 HOH B1372 SITE 2 AC2 6 HOH B1384 HOH B1437 SITE 1 AC3 11 TYR A 8 GLY A 13 ARG A 14 ASP A 96 SITE 2 AC3 11 MET A 99 TRP A 104 TYR A 152 THR A 159 SITE 3 AC3 11 LEU A 199 GSH A 201 HOH A 461 SITE 1 AC4 15 ASP A 97 TYR B1008 ARG B1014 TRP B1039 SITE 2 AC4 15 LYS B1043 LYS B1050 ILE B1051 GLN B1063 SITE 3 AC4 15 SER B1064 HOH B1309 HOH B1353 HOH B1404 SITE 4 AC4 15 HOH B1430 HOH B1438 HOH B1649 CRYST1 48.740 77.706 52.449 90.00 91.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020517 0.000000 0.000559 0.00000 SCALE2 0.000000 0.012869 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019073 0.00000 MASTER 266 0 4 20 8 0 14 6 0 0 0 32 END